Site-Specific N-Linked Glycosylation Analysis of Human Carcinoembryonic Antigen by Sheathless Capillary Electrophoresis-Tandem Mass Spectrometry

  • Laura Pont
  • , Valeriia Kuzyk
  • , Fernando Benavente*
  • , Victoria Sanz-Nebot
  • , Oleg A. Mayboroda
  • , Manfred Wuhrer
  • , Guinevere S.M. Lageveen-Kammeijer
  • *Corresponding author for this work

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

With 28 potential N-glycosylation sites, human carcinoembryonic antigen (CEA) bears an extreme amount of N-linked glycosylation, and approximately 60% of its molecular mass can be attributed to its carbohydrates. CEA is often overexpressed and released by many solid tumors, including colorectal carcinomas. CEA displays an impressive heterogeneity and variability in sugar content; however, site-specific distribution of carbohydrate structures has not been reported so far. The present study investigated CEA samples purified from human colon carcinoma and human liver metastases and enabled the characterization of 21 out of 28 potential N-glycosylation sites with respect to their occupancy. The coverage was achieved by a multienzymatic digestion approach with specific enzymes, such as trypsin, endoproteinase Glu-C, and the nonspecific enzyme, Pronase, followed by analysis using sheathless CE-MS/MS. In total, 893 different N-glycopeptides and 128 unique N-glycan compositions were identified. Overall, a great heterogeneity was found both within (micro) and in between (macro) individual N-glycosylation sites. Moreover, notable differences were found on certain N-glycosylation sites between primary adenocarcinoma and metastatic tumor in regard to branching, bisection, sialylation, and fucosylation. Those features, if further investigated in a targeted manner, may pave the way toward improved diagnostics and monitoring of colorectal cancer progression and recurrence. Raw mass spectrometric data and Skyline processed data files that support the findings of this study are available in the MassIVE repository with the identifier MSV000086774 [DOI: 10.25345/C5Z50X].

Original languageEnglish
Pages (from-to)1666-1675
Number of pages10
JournalJournal of Proteome Research
Volume20
Issue number3
Early online date9 Feb 2021
DOIs
Publication statusPublished - 5 Mar 2021

Bibliographical note

Publisher Copyright:
© 2021 The Authors. Published by American Chemical Society.

Funding

This study was supported by the European Union (Horizon 2020 Framework Programme; Marie Curie European Training Network, GlyCoCan project, Grant Number 676421 and Seventh Framework Programme HighGlycan and IBD-BIOM, Grant Numbers 278535 and 305479), a grant Spanish Ministry of Economy and Competitiveness (RTI2018-097411-B-I00), a Horizon Programme Zenith project of The Netherlands Genomic Initiative (Project No. 93511033) and SCIEX. L.P. acknowledges the Spanish Ministry of Economy and Competitiveness for a FPI fellowship (BES-2012-061127) and a short stay fellowship (EEBB-I-16-11506). We thank Rob Haselberg for his input on the manuscript.

FundersFunder number
IBD-BIOM
European Commission
Seventh Framework Programme HighGlycan
Marie Curie European Training Network
Ministerio de Economía y CompetitividadRTI2018-097411-B-I00
Seventh Framework Programme278535, 305479
Horizon Programme Zenith project of The Netherlands Genomic Initiative93511033
Horizon 2020 Framework Programme676421
SCIEXEEBB-I-16-11506, BES-2012-061127

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • bottom-up proteomics
    • carcinoembryonic antigen
    • CE-MS
    • CEACAM5
    • colorectal cancer
    • glycomics
    • glycopeptide
    • glycosylation

    Fingerprint

    Dive into the research topics of 'Site-Specific N-Linked Glycosylation Analysis of Human Carcinoembryonic Antigen by Sheathless Capillary Electrophoresis-Tandem Mass Spectrometry'. Together they form a unique fingerprint.

    Cite this